• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道疾病中的免疫调节:治疗性肽的新机遇?

Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides?

作者信息

de Jonge Wouter J, Greaves David R

机构信息

Laboratory of Experimental Gastroenterology and Hepatology, Academic Medical Center Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

出版信息

Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):741-8. doi: 10.1586/17474124.2.6.741.

DOI:10.1586/17474124.2.6.741
PMID:19090735
Abstract

Inflammation is the response of vascularized tissues to injury, irritation and infection. Nearly always, the inflammatory response is successfully resolved and, when necessary, a process of wound healing is initiated. Nowhere in the body is this homeostatic process more challenging than in the gastrointestinal (GI) tract, where the microbial flora sits in very close proximity to the mucosal immune system, separated only by an epithelial cell barrier. Delicate regulatory systems of the mucosal immune system determine mucosal permeability and response to bacterial flora, and aberrations in this system result in acute or chronic inflammatory conditions. Examples of such are two commonly occurring inflammatory GI disorders: inflammatory bowel disease and postoperative ileus. Inflammatory bowel disease is the result of a chronic and excessive mucosal immune response, whereas postoperative ileus represents a transient condition of GI tract paralysis that is the result of an inflammatory response to abdominal surgery. The clinical management of both conditions is very challenging and depends heavily on the possibility of modulating the host immune response. In this brief report, we highlight the role of neuropeptides in GI physiology and immune regulation, discuss a recently discovered endogenous anti-inflammatory pathway mediated by the ChemR23 receptor and speculate on the therapeutic potential of peptides that bind G-protein-coupled receptors in the management of inflammation in the GI tract.

摘要

炎症是血管化组织对损伤、刺激和感染的反应。几乎在所有情况下,炎症反应都能成功消退,必要时还会启动伤口愈合过程。在人体中,这种稳态过程在胃肠道面临的挑战最大,因为微生物菌群与黏膜免疫系统紧密相邻,仅由一层上皮细胞屏障分隔。黏膜免疫系统的精细调节系统决定了黏膜通透性以及对细菌菌群的反应,该系统的异常会导致急性或慢性炎症状态。常见的两种炎症性胃肠道疾病就是例证:炎症性肠病和术后肠梗阻。炎症性肠病是慢性且过度的黏膜免疫反应的结果;而术后肠梗阻则是胃肠道麻痹的一种短暂状态,是腹部手术引发炎症反应的结果。这两种病症的临床治疗都极具挑战性,且在很大程度上依赖于调节宿主免疫反应的可能性。在本简要报告中,我们着重阐述神经肽在胃肠道生理和免疫调节中的作用,讨论最近发现的由ChemR23受体介导的内源性抗炎途径,并推测与G蛋白偶联受体结合的肽在胃肠道炎症治疗中的潜力。

相似文献

1
Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides?胃肠道疾病中的免疫调节:治疗性肽的新机遇?
Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):741-8. doi: 10.1586/17474124.2.6.741.
2
Neuropeptides as pleiotropic modulators of the immune response.神经肽作为免疫反应的多效调节剂。
Neuroendocrinology. 2011;94(2):89-100. doi: 10.1159/000328636. Epub 2011 Jul 7.
3
Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?抗炎神经肽受体:免疫紊乱的新治疗靶点?
Trends Pharmacol Sci. 2007 Sep;28(9):482-91. doi: 10.1016/j.tips.2007.07.001. Epub 2007 Aug 3.
4
Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.可体他汀作为炎症性疾病的潜在多步治疗剂。
Drug News Perspect. 2006 Sep;19(7):393-9. doi: 10.1358/dnp.2006.19.7.1021490.
5
Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.可体他汀作为一种在免疫紊乱中具有治疗潜力的新型免疫调节因子的出现。
Mol Cell Endocrinol. 2008 May 14;286(1-2):135-40. doi: 10.1016/j.mce.2007.08.001. Epub 2007 Aug 7.
6
The hedgehog signalling pathway in the gastrointestinal tract: implications for development, homeostasis, and disease.胃肠道中的刺猬信号通路:对发育、稳态及疾病的影响
Gastroenterology. 2005 Nov;129(5):1696-710. doi: 10.1053/j.gastro.2005.05.010.
7
Neuromedin U: physiology, pharmacology and therapeutic potential.神经介素U:生理学、药理学及治疗潜力
Fundam Clin Pharmacol. 2009 Apr;23(2):149-57. doi: 10.1111/j.1472-8206.2009.00667.x.
8
Targeting mast cells in the treatment of functional gastrointestinal disorders.靶向肥大细胞治疗功能性胃肠疾病。
Curr Opin Pharmacol. 2006 Dec;6(6):541-6. doi: 10.1016/j.coph.2006.08.001. Epub 2006 Sep 7.
9
Basic and clinical overview of the mucosal immune system.
Semin Gastrointest Dis. 1996 Jan;7(1):2-11.
10
Imaging techniques: new insights into chemokine/chemokine receptor biology at the immune system.成像技术:免疫系统中趋化因子/趋化因子受体生物学的新见解。
Pharmacol Ther. 2008 Jul;119(1):24-32. doi: 10.1016/j.pharmthera.2008.04.007. Epub 2008 May 18.

引用本文的文献

1
The Gut's Little Brain in Control of Intestinal Immunity.控制肠道免疫的肠道“小脑”
ISRN Gastroenterol. 2013 Apr 4;2013:630159. doi: 10.1155/2013/630159. Print 2013.